Label: SENNA-LAX- sennosides tablet
- NDC Code(s): 68998-373-01
- Packager: Marc Glassman, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 27, 2016
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that continues over a period of 2 weeks
-
Directions
- take preferably at bedtime or as directed by a doctor
Age Starting dosage Maximum dosage Adults and children over 12 years 2 tablets once a day 4 tablets twice a day Children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
Children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day Children under 2 years consult a doctor consult a doctor - take preferably at bedtime or as directed by a doctor
- Other information
- Inactive ingredients
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
SENNA-LAX
sennosides tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68998-373 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color brown Score no score Shape ROUND Size 8mm Flavor Imprint Code AZ;217 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68998-373-01 1 in 1 CARTON 07/01/2014 1 100 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M007 07/01/2014 Labeler - Marc Glassman, Inc. (094487477)